Daniel Roller
About Daniel Roller
Daniel Roller is a Key Account Manager at BeiGene with over 18 years of experience in the pharmaceutical industry, specializing in key account management.
Company
Daniel Roller is currently employed at BeiGene as a Key Account Manager responsible for the Nordbayern region. BeiGene is a biotechnology company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer. Daniel's role involves managing and nurturing strategic accounts in his designated area.
Previous Roles at Alexion Pharmaceuticals
From 2021 to 2022, Daniel Roller worked at Alexion Pharmaceuticals, Inc. as a Key Account Manager in Nürnberg, Bayern, Deutschland. In this role, he was responsible for managing key accounts, fostering client relationships, and ensuring the satisfaction and retention of key stakeholders within the pharmaceutical sector.
Previous Roles at Portola Pharmaceuticals
From 2019 to 2021, Daniel Roller was employed at Portola Pharmaceuticals as a Senior Key Account Manager. During this period, he was involved in high-level account management, providing specialized services and support to critical accounts, and maintaining robust client interactions.
Roles at Celgene
Daniel Roller held a position as Spezialaußendienst Inflammation & Immunology at Celgene from 2016 to 2019 in Nürnberg, Bayern, Deutschland. In this role, he specialized in the areas of inflammation and immunology, contributing significantly to the company's initiatives in these medical fields through expert account management and client engagement.
Career in Key Account Management
Daniel Roller has accumulated over 18 years of experience in the pharmaceutical industry, with a strong focus on key account management. His career includes roles at well-known companies such as Fresenius Medical Care, UCB, and Schwarz Pharma. Throughout his career, he has consistently managed key accounts, fostering critical client relationships and ensuring business growth and client satisfaction within the pharmaceutical sector.